Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19
中等剂量依诺肝素治疗中重度 COVID-19 住院患者:一项 II 期单臂试点研究,INHIXACOVID19
期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-023-08297-7
Cosmi, B; Giannella, M; Fornaro, G; Cristini, F; Patacca, A; Castagna, A; Mazzaferri, F; Testa, S; Pan, A; Lupi, M; Brambilla, P; Montineri, A; Frattima, S; Bignami, E G; Salvetti, M; De Stefano, G; Grandone, E; Di Perri, G; Rozzini, R; Stella, A; Romagnoli, A; Drago, F; Viale, P